Search
Now showing items 1-10 of 21
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Ruecker, Frank G. et al. (2019)
Wissenschaftlicher Artikel
IGF1R as druggable target mediating PI3K-delta inhibitor resistance in a murine model of chronic lymphocytic leukemia
Scheffold, Annika et al. (2019)
Wissenschaftlicher Artikel
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Cocciardi, Sibylle et al. (2019)
Wissenschaftlicher Artikel
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
Jawhar, Mohamad et al. (2019)
Wissenschaftlicher Artikel
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia
Döhner, Hartmut et al. (2019)
Wissenschaftlicher Artikel
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia
Jebaraj, Billy Michael Chelliah et al. (2019)
Wissenschaftlicher Artikel
Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study
Huetter-Kroenke, Marie Luise et al. (2019)
Wissenschaftlicher Artikel
Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation
Thanh Mai Nguyen et al. (2019)
Wissenschaftlicher Artikel
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Sanz, Miguel A. et al. (2019)
Wissenschaftlicher Artikel
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
Schlenk, Richard Friedrich et al. (2019)
Wissenschaftlicher Artikel